Summary:
- The article discusses a partnership between the Coalition for Epidemic Preparedness Innovations (CEPI) and the Serum Institute of India to develop vaccines targeting the H5N1 influenza virus, which has the potential to cause a pandemic.
- The partnership aims to accelerate the development and manufacturing of these vaccines, ensuring they are available and accessible in the event of an H5N1 outbreak.
- This collaboration is part of CEPI's efforts to strengthen global pandemic preparedness and response capabilities, focusing on developing vaccines for emerging infectious diseases that pose a significant threat to public health.